Huntington's disease (HD) is a neurodegenerative disease associated with extensive down-regulation of genes controlling neuronal function, particularly in the striatum. Whether altered epigenetic regulation underlies transcriptional defects in HD is unclear. Integrating RNA-sequencing (RNA-seq) and chromatin-immunoprecipitation followed by massively parallel sequencing (ChIP-seq), we show that down-regulated genes in HD mouse striatum associate with selective decrease in H3K27ac, a mark of active enhancers, and RNA Polymerase II (RNAPII). In addition, we reveal that decreased genes in HD mouse striatum display a specific epigenetic signature, characterized by high levels and broad patterns of H3K27ac and RNAPII. Our results indicate that this signature is that of super-enhancers, a category of broad enhancers regulating genes defining tissue identity and function. Specifically, we reveal that striatal super-enhancers display extensive H3K27 acetylation within gene bodies, drive transcription characterized by low levels of paused RNAPII, regulate neuronal function genes and are enriched in binding motifs for Gata transcription factors, such as Gata2 regulating striatal identity genes. Together, our results provide evidence for preferential down-regulation of genes controlled by super-enhancers in HD striatum and indicate that enhancer topography is a major parameter determining the propensity of a gene to be deregulated in a neurodegenerative disease. †
Introduction
Increasing evidence indicates that epigenetic regulation contributes to the etiology of neurodegenerative diseases. The phenotype of several mouse models of neurodegenerative diseases, including Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis and Huntington's disease (HD), is improved upon treatment with histone deactetylase (HDAC) inhibitors, suggesting that defects in histone acetylation are central to pathogeneses (1) . However, the precise location, the extent and the transcriptional consequences of changes in histone acetylation in affected neurons are unclear, thus limiting the development of selective epigenetic therapies for these diseases.
HD is a genetically well-defined and tractable neurodegenerative disease, for which mouse models that are particularly suitable to epigenomic analyses have been generated. HD mice recapitulate major features of the disease, including extensive transcriptional misregulation in the striatum, the region that is preferentially affected (2) (3) (4) (5) (6) (7) (8) . Comparative analyses of data from the striatum of several HD mice and the caudate nucleus of HD patients revealed a common gene expression signature that is strongly enriched in biological processes and pathways related to neuronal activity and identity (2, 4, 5) . Although studies indicate that decreased activity of histone acetyl transferase CBP in HD neurons might lead to decreased histone acetylation and consequently decreased gene expression (2, (9) (10) (11) (12) (13) (14) , the mechanism underlying transcriptional misregulation in response to the HD mutation is unclear. In a recent study, the analysis of acetylation of H3K9, H3K14 and H4K12 in hippocampus and cerebellum of HD transgenic N171-82Q mice using chromatin immunoprecipitation followed by massive parallel sequencing (ChIP-seq) showed that most local acetylation deficits are not associated with changes in transcription (15) . These histone modifications are essentially increased at promoter regions as opposed to distal regulatory regions like enhancers. Whether deficits in acetylation at enhancer regions underlie transcriptional alterations in HD has not been investigated.
Acetylation of H3K27 (H3K27ac), a bona-fide target of CBP (16) , is a mark of active enhancers (17) (18) (19) . Recent studies clustered enhancers in two categories, including typical enhancers and the so-called super-enhancers (20, 21) . In contrast to typical enhancers, super-enhancers are large in size and characterized by high levels and broad patterns of H3K27ac (20, 22) . They are established during development by master transcription factors, are highly sensitive to perturbation of their components and drive expression of genes that define cell identity and control cell-type-specific functions (20, 23) . Enhancers facilitate transcription via long-range interactions, regulating RNA Polymerase II (RNAPII) recruitment and activity (24) . The mechanism involves enhancer-mediated release of paused RNAPII from promoters, enabling transcription elongation (25, 26) .
Here, we have integrated ChIP-seq and RNA-sequencing (RNA-seq) to examine the role of H3K27ac in HD transcriptional misregulation. We show that H3K27ac and RNAPII are specifically decreased at down-regulated genes in the striatum of HD transgenic R6/1 mice. Moreover, we provide evidence for preferential down-regulation of genes that are under the control of broad enhancers characterized by extended and high levels of H3K27ac. These broad enhancers regulate genes controlling neuronal function and identity and are enriched in binding motifs recognized by Gata2, a master transcription factor of striatal specification (27) , indicating that they define striatal super-enhancers. Finally, we show that striatal broad enhancers regulate highly expressed genes that are characterized by low RNAPII promoter pausing, suggesting that enhancer topography influences RNAPII dynamics. Together, our data support the view that down-regulation of neuronal function genes in HD striatum results from selective decrease in H3K27 acetylation at super-enhancers, causing reduction of RNAPII and transcription at genes controlled by super-enhancers.
Results
Gene expression changes in the striatum of HD R6/1 transgenic mice consist predominantly of downregulated genes
We analyzed gene expression in the striatum of R6/1 and control mice at a late pathological stage (30 weeks) by mRNA-seq identifying 1230 down-regulated genes in R6/1 relative to wild-type (WT), whereas 706 genes were up-regulated (Supplementary Material, Table S1 ). Globally, stronger changes were seen for down-regulated genes compared with up-regulated genes (Supplementary Material, Fig. S1A , showing 20 top-ranked genes of each list). Gene ontology (GO) analysis using DAVID (28) showed that down-regulated genes were strongly enriched in cellular components (CCs), molecular functions (MFs) and pathways (KEGG/BIOCARTA) related to neuronal activity, in contrast to up-regulated genes that showed no enrichment in specific functions or pathways (Supplementary Material, Fig. S1B ). Similar conclusions were made when gene lists were restricted to 300 top-ranked down-and up-regulated genes using GREAT (29) as an alternative annotation tool (Supplementary Material, Fig. S2 ). Down-regulated genes are strongly enriched in functions and pathways related to calcium signaling, channel activity, glutamate receptor activity, GTPase regulator activity and synaptic transmission, which is in accordance with previous studies on HD mice and patients (2, 3, 30, 31) . Top-ranked down-regulated genes included striatal markers such as Pde10, Ppp1r1b (Darpp-32) and Drd2 (ranking 6th, 33rd and 5th, respectively; Supplementary Material, Table S1 ), previously found decreased in the striatum of HD mice and patients (3, 32, 33) . Down-regulation of these genes was confirmed by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR; Supplementary Material, Fig. S3A ).
Our set of genes deregulated in R6/1 striatum overlapped with that resulting from previous analysis of microarray data generated from R6/1 total brain (6) , indicating consistency between datasets (Supplementary Material, Fig. S3B ). We then compared our list of down-regulated genes in R6/1 striatum with a list of genes defining specifically the HD striatal transcriptome signature and consisting of 60 top-ranked genes presenting early and concordant changes (e.g. decreased expression) in the striatum of HD patients and mice, including R6/1 and R6/2 mice (4). Thirty-eight of these 60 genes (63%) were also down-regulated in R6/1 striatum ( Fig. 1A and Supplementary Material, Table S2 ), indicating that our RNA-seq data recapitulated to a large extent the previously defined HD transcriptome signature (4) . In addition, we assessed the overlap between down-regulated genes in the striata of our R6/1 mice and the R6/2 model (8) . Of 467 genes down-regulated in the R6/2 striatum, 297 (64%) were decreased in the striatum of both mouse strains ( Fig. 1B and Supplementary Material, Table S2 ). In contrast, the overlap between up-regulated genes in the striata of R6/1 and R6/2 mice was only 27% ( Fig. 1B and Supplementary Material, Table S2 ). Similarly, 63% of the genes downregulated in the striatum of the HD CHL2 knock-in mouse model were also decreased in R6/1 striatum (4), whereas common upregulated genes between CHL2 and R6/1 striata were fewer (37%; Fig. 1C and Supplementary Material, Table S2 ). Thus, down-regulated genes are highly conserved between HD mouse models and patients, in contrast to up-regulated genes.
H3K27ac occupancy, a mark of active enhancers, on the chromatin of striatal extracts prepared from R6/1 and control mice, using ChIP-seq. Two independent biological replicates were generated to ensure data reproducibility (see Materials and Methods and Supplementary Material, Figs S4A, S7A and B). H3K27 is acetylated by CBP that has been implicated in HD pathogenesis in several studies (2) . H3K27ac peaks were preferentially located in introns and promoters ( Fig. 2A ). Overall, H3K27ac peaks between R6/1 and WT samples were highly correlated (Supplementary Material, Fig. S4 ), however a subclass of peaks throughout the genome displayed significant changes with regions showing both decreased and increased occupancy in R6/1 relative to WT (Supplementary Material, Table S3 ). We integrated H3K27ac ChIP-seq and RNA-seq data and determined global expression levels of genes associated with genomic regions presenting decreased or increased H3K27ac occupancy in R6/1 versus WT mice ( Fig. 2B ). Although decreased H3K27ac occupancy in R6/1 correlated with decreased expression of the associated genes, increased H3K27ac occupancy did not correlate with increased expression of associated genes ( Fig. 2B ), suggesting that transcription was more impacted by decrease than increase in H3K27ac. To further explore this possibility, we assessed the level of H3K27ac at deregulated genes. H3K27ac occupancy was significantly decreased at down-regulated genes in R6/1 striatum, whereas it was not significantly increased at up-regulated genes, nor was it globally changed when considering all expressed genes (Fig. 2C , D and Supplementary Material, Fig. S5A ). H3K27ac occupancy at down-regulated genes showed strong enrichment at the TSS as well as throughout the gene body. In contrast, the mean H3K27ac occupancy profile on all expressed genes showed a predominant sharp peak at the TSS with little marking of the gene body ( Fig. 2D ). The down-regulated genes therefore display a specific profile distinct from the mean profile.
GO analysis using GREAT (29) revealed that genes and pathways regulating calcium channel activity and synaptic transmission were most significantly enriched among genomic regions presenting decreased H3K27ac in R6/1, whereas functions and pathways enriched with H3K27ac in R6/1 were not specifically involved in neuronal activity ( Supplementary Material, Fig. S5B ). The reproducibility of the results was verified with a second independent ChIP-seq experiment, showing a high correlation between the two datasets (Supplementary Material, Figs S4 and S7). Thus, genes with reduced expression show a specific H3K27ac profile whose levels correlate with their expression, whereas no correlation between increased H3K27ac occupancy and gene expression was observed.
To further examine the status of enhancers at downregulated genes in R6/1 mice, we performed ChIP-seq using an antibody to monomethylated H3K4 (H3K4me1), a histone modification that precedes acetylation of H3K27 and marks both active and poised enhancers (Supplementary Material, Fig. S4 ). Accordingly, H3K27ac and H3K4me1 regions were highly correlated and >90% of H3K27ac peaks coincided with H3K4me1 peaks ( Fig. 2E and Supplementary Material, Fig. S4D ). However, in contrast to H3K27ac ChIP-seq results, the level of H3K4me1 at downregulated genes was only mildly decreased ( Fig. 2E ), suggesting that the HD mutation primarily results in alteration of active enhancers regulated by histone acetylation.
RNAPII occupancy is decreased at down-regulated genes
Enhancers, whose activity depends upon H3K27ac levels, control transcription, influencing RNAPII recruitment and dynamics (24) . To decipher the mechanism possibly linking decreased H3K27ac and gene down-regulation in R6/1 mice, we performed RNAPII ChIP-seq experiments on R6/1 and WT striatum (Supplementary Material, Fig. S4 ). Overall, RNAPII peak distribution was comparable between R6/1 and WT striatum and, as expected, strongest occupancy was observed at promoters ( Fig. 3A ). Similar to H3K27ac, differential RNAPII occupancy between R6/1 and WT was seen at specific loci (Supplementary Material, Table S4 ). Genes presenting decreased RNAPII occupancy in R6/1 striatum showed decreased expression, whereas expression of genes showing increased RNAPII occupancy in R6/1 was not changed (Fig. 3B ). Expression of genes showing increased RNAPII occupancy in R6/1 was globally lower than that of genes exhibiting decreased RNAPII occupancy ( Fig. 3B ). It is likely that RNAPII increases at low or non-expressed genes may not be sufficient to significantly modify overall expression levels, whereas highly expressed genes may be more sensitive to decreased RNAPII. Examination of RNAPII at genes deregulated in R6/1 striatum showed that similar to H3K27ac, RNAPII was significantly decreased at down-regulated genes, but was not substantially changed at up-regulated genes or globally ( Fig. 3C and D). Higher levels of RNAPII were detected in gene bodies of down-regulated genes in comparison to all expressed genes ( Fig. 3D ).
Functional enrichment analysis of genomic regions differentially occupied by RNAPII using GREAT showed that genes associated with decreased RNAPII in the R6/1 striatum were strongly enriched in GO terms and MSigDB pathways related to neuronal activity, including synaptic transmission and calcium signaling (Supplementary Material, Fig. S6B ), consistent with analyses using RNA-seq and H3K27ac ChIP-seq datasets (Supplementary Material, Figs S1, S2 and S5B). In contrast, no clear functional enrichments were observed for regions showing increased RNAPII in R6/1. The reproducibility of the results was verified with a second independent experiment, showing a high level of correlation between the two datasets (Supplementary Material, Figs S4A and S7).
In conclusion, these data show a strong association between decreased gene expression and reduction of H3K27ac and RNAPII occupancy, supporting the view that down-regulated genes in R6/ 1 striatum result from decreased H3K27ac and reduction of RNA-PII. They also suggest that genes regulating neuronal function are more specifically sensitive to loss of H3K27ac and RNAPII. Our data also show poor correlation between up-regulated genes and H3K27ac and RNAPII levels, suggesting that different mechanisms underlie down-and up-regulation of genes in HD.
Down-regulated genes in R6/1 striatum have low RNAPII pausing index and associate with broad enhancer regions
The above results suggest that down-regulated genes might share common regulatory features. H3K27ac and RNAPII profiles at down-regulated genes, including Pde10a, Darpp32 and Drd2, were broad, spreading throughout gene bodies, in contrast to sharp TSS peaks at genes showing no changes in expression between R6/1 and WT, for instance Atrx, Htt and Jarid1c ( Fig. 4A and B). Thus, genes down-regulated in R6/1 striatum might share common H3K27ac and RNAPII signatures.
To explore this possibility, we integrated H3K27ac and RNAPII ChIP-seq gene profiles as a read density map of H3K27ac and RNAPII from the TSS to the transcription termination site (TTS) ( Fig. 5A ). Remarkably, H3K27ac and RNAPII gene profiles were highly correlated and clustered into six distinct classes (clusters A-F; Fig. 5A ). Genes in cluster A exhibited elevated levels of both H3K27ac and RNAPII along the entire gene, whereas H3K27ac and RNAPII marked more specifically the TSS region of genes in Human Molecular Genetics | 7 by guest on November 7, 2016 http://hmg.oxfordjournals.org/ clusters B, C, D and E. Last, cluster F contained genes with very low levels of H3K27ac and RNAPII, both at TSS and gene body. Using RNA-seq data on R6/1 and WT striatum, we assessed gene expression level within each cluster ( Fig. 5B ). Noticeably, clusters A, B, C and D, although defining different epigenetic profiles, contained genes that were globally expressed to comparable and high levels, in contrast to clusters E and F, which contained low and non-expressed genes, respectively. Basal expression of down-regulated genes in R6/1 striatum was globally high when compared with that of clusters A-E ( Fig. 5B ). Transcriptional activity of a majority of genes is regulated through high levels of paused RNAPII at promoters, whereas a small subset of expressed genes displays RNAPII levels that are low at promoters and high in gene bodies (34) . We quantified RNAPII pausing at promoters of highly expressed genes in clusters A-D by measuring the pausing index (PI; Fig. 5C ) as the ratio between RNAPII densities at the TSS versus gene body (35) . As expected, pausing indices were the lowest in genes of cluster A. We verified that gene size in cluster A was not globally different from that in the other clusters (Supplementary Material, Fig. S7C ). Thus, genes in cluster A are not regulated mainly through promoter-proximal pausing, in contrast to genes of the other clusters. Interestingly, PI of down-regulated genes in R6/1 striatum was also low and comparable to that of cluster A ( Fig. 5C ), suggesting that downregulated genes might predominantly belong to cluster A.
We examined this hypothesis, assessing the number of downregulated genes in each cluster (Fig. 5D ). Remarkably, cluster A was significantly enriched in down-regulated genes, all the more since genes were highly significantly down-regulated ( Fig. 5D and Supplementary Material, Fig. S8A ). The number of down-regulated genes in cluster A was 6-fold more than expected when considering the 300 top-ranked genes down in R6/1 striatum and 2.5-fold more when considering the full list of genes down in R6/1 striatum (i.e. 1230 genes). Down-regulated genes in striatum of another HD mouse (e.g. R6/2 mouse; (8)) were also enriched in cluster A (>5-fold higher than expected; Supplementary Material, Fig. S8B ). Thus, genes showing decreased expression belonged predominantly to cluster A. In contrast, clusters B, C, D and E were not enriched or were even depleted in down-regulated genes. Cluster F was not included in the calculation, as it contains non-expressed genes. Up-regulated genes were not enriched in cluster A or in other clusters (Fig. 5D ). In consequence, down-regulated genes in R6/1 and R6/2 mouse striatum display a defined enhancer topography consisting of broad H3K27ac profiles encompassing genes and specific transcription dynamics characterized by a low RNAPII PI.
We then investigated whether the above-identified clusters were enriched in genes defining HD transcriptomic signature (4). Remarkably, cluster A also contained ≈6-fold more genes of HD striatal transcriptomic signature than expected ( Fig. 5E ). Approximately half of the 60 genes are present in cluster A. Finally, selecting top-ranked down-regulated genes in HD human caudate, as assessed by Hodges et al. (5) , we determined the number of mouse genes orthologous to human down-regulated genes in each cluster (Fig. 5E ). Cluster A was strongly enriched in genes down-regulated in HD human caudate nucleus, in contrast to the other clusters. Thus, the HD epigenetic signature identified using R6/1 striatum is conserved between humans and mice.
Cluster A is enriched in genes involved in neuronal activity
Functional enrichment analysis of the different clusters using GREAT showed that cluster A was significantly enriched in terms and pathways involved in neuronal activity and signaling (Supplementary Material, Figs S9 and S10), consistent with the enrichment of down-regulated genes in R6/1 in cluster A. In contrast, genes of clusters B and D were strongly associated with translation and mitochondrial functions, whereas genes of cluster C appeared linked to membrane trafficking, signaling and post-translational modification of proteins (Supplementary Material, Figs S9 and S10). Thus, our data reveal that neuronal activity in striatum is predominantly under the control of genes exhibiting a specific epigenetic signature and RNAPII dynamics. Thus, the increased susceptibility to down-regulation of genes of cluster A likely contributes to specific alteration of neuronal function in HD striatum.
Down-regulated genes that associate with increased RNAPII PI in R6/1 striatum have a broad effect on neuronal activity
To further investigate the functional relationship between RNA-PII dynamics and deregulated genes in R6/1 striatum, we performed a network-based analysis on RNA-seq data and RNAPII pausing indices (see Materials and Methods). Four classes were generated (classes 1-4), which consisted of down-or upregulated genes associated with either increased or decreased RNAPII PI. We explored the biological significance of these four classes to identify the most robust pathophysiological trends in the R6/1 mouse striatum. Compared with classes 2-4, class 1, corresponding to down-regulated genes associated with increased PI in R6/1 striatum (Supplementary Material, Table S5 ), suggests the largest biological impact as inferred from KEGG pathway annotations ( Supplementary Material, Fig. S11 ). Classes 1-4 greatly differed by virtue of their pathway content (Supplementary Material, Fig. S10 ). Signatures containing gene families and biological processes (BP) were identified in each class (Supplementary Material, Figs S12-S15 and Supplementary Material, Table S6 ). These signatures contained several BPs uniquely enriched in each class, highlighting neuronal activity in class 1 (e.g. adenylate cyclase), cell redox in class 2 (e.g. anion exchange), chromatin modification in class 3 (e.g. HDAC activity) and protein processing and response to stress in class 4 (e.g. peptidase activity). Thus, down-regulated genes that display increased RNAPII PI in R6/1 striatum, resulting essentially from higher reduction of RNAPII in gene bodies than promoters, are characterized by a neuronal signature and have a strong impact on striatal neuron activity in the R6/1 mouse. These results support the notion that decreased RNAPII level within gene bodies of neuronal genes is a critical parameter contributing to transcriptional misregulation of neuronal function genes in HD striatum.
Super-enhancers control down-regulated genes in R6/1 striatum
Recent studies identified super-enhancers, a category of large enhancers characterized by broad H3K27ac patterns and regulating tissue-identity genes (20) . Our results showing that downregulated genes in R6/1 striatum associate with broad H3K27ac profiles and control neuron-specific genes therefore suggest that they might be under the control of super-enhancers. As superenhancers are enriched in binding motifs for tissue-specific master transcription factors, we investigated whether down-regulated genes in R6/1 striatum would contain specific DNA motifs. By using a DNA motif analysis (see Materials and Methods), we show that gene bodies of down-regulated genes are significantly enriched in four DNA motifs, including three motifs relevant to neuronal function such as motifs for neuron-restrictive silencer factor (NRSF/REST) (36) , retinoic-acid induced receptors (NR1H2-RXRA) (37) and Gata transcription factors (27) (Fig. 6A ). Although motifs for NRSF/REST and NR1H2-RXRA were also enriched in genes of clusters A-D and therefore were not specific, the Gata motif was specifically enriched in down-regulated genes (Fig. 6B-D) . Interestingly, the Gata2 transcription factor, a master gene highly expressed in midbrain during development, is required for specification of striatal gabaergic medium spiny neurons (27) .
Thus, enhancers associated with down-regulated genes in R6/1 striatum meet criteria defining functional attributes of superenhancers: (i) they are broad in size, (ii) they mark highly expressed genes defining tissue identity and function and (iii) they are enriched in master transcription factor binding sites. In addition, our results showing that super-enhancers in striatum broadly overlap with the body of genes they control and associate with genes characterized by low RNAPII PI reveal new functional attributes of super-enhancers in this tissue. Stabilization rather than establishment of striatal super-enhancers is impaired in R6/1 striatum In the brain, Gata2 expression is restricted to a defined window of time corresponding to developing midbrain (27) . This is in agreement with our results showing that Gata2 is present at residual levels in the adult mouse striatum and is absent in the cerebellum, a tissue that is not dependent on Gata2 during development ( Fig. 7A and Supplementary Material, Table S1 ). Gata factors, including Gata3 and Gata4, are involved in the establishment of tissuespecific enhancers (e.g. super-enhancers) (39, 40) , suggesting that Gata2 may promote the establishment of striatal super-enhancers. Gata2 was not decreased and was even slightly increased in the adult R6/1 striatum when compared with WT ( Fig. 7A and Supplementary Material, Table S1 ). Together with our H3K27ac ChIP-seq data showing a high degree of correlation between R6/1 and WT H3K27ac peaks ( Fig. 2A, Supplementary Material, Figs S4B , C and S7B), these results suggest that the HD mutation does not substantially alter the establishment of striatal super-enhancers during development. Alternatively, stabilization of super-enhancers in striatal differentiated neurons may be impaired.
CBP activity is progressively altered in HD neurons, due to sequestration into nuclear aggregates of mutant HTT and/or aberrant interaction with soluble mutant HTT leading to increased CBP degradation (2, 9, 12) , a result that is consistent with the slight decrease in CBP protein level observed in R6/1 striatum (Fig. 7A ). As CBP, which acetylates H3K27, is a component of super-enhancers (16, 22) , we investigated whether decreased genes in R6/1 striatum may be regulated by CBP. To this end, we used CBP ChIP-seq data generated in primary neurons that were either left untreated or treated with KCl to mimic neuronal activation (38) . We compared CBP occupancy at down-and up-regulated genes in R6/1 striatum (Fig. 7B ). Although CBP occupancy at down-and up-regulated genes was similar in the untreated condition, upon KCl treatment, the level of CBP was significantly higher at down-than up-regulated genes. Thus, neuronal activation has a stronger effect on CBP binding at down-regulated genes, indicating that decreased genes in R6/1 striatum are more responsive to CBP regulation than increased genes. This result is consistent with the increased sensitivity of superenhancers, in comparison to typical enhancers, to perturbation of their components (20, 23) .
In conclusion, our data show that super-enhancer-regulated genes, controlling tissue-specific identity and function, are preferentially down-regulated in HD striatum, due to a selective decrease in H3K27ac and RNAPII at super-enhancer regions. We propose that the HD mutation results in defect in the stabilization of striatal super-enhancers, and perturbation of CBP activity contributes to this mechanism (Fig. 7C ).
Discussion
We show a specific decrease in RNAPII and H3K27ac at downregulated genes in the HD R6/1 mouse striatum. H3K27ac facilitates the recruitment of transcriptional activators and subsequently RNAPII, suggesting that decreased H3K27ac at specific genes in R6/1 striatum may be the principal cause of their reduced expression. In addition, we demonstrate that most down-regulated genes in R6/1 striatum share a defined signature, displaying distinct functional, epigenetic and DNA sequence features. Specifically, down-regulated genes in R6/1 striatum are enriched in functions and pathways regulating neuronal activity, display extended and high occupancy of H3K27ac and are enriched in Gata motifs, recognized by a master gene of striatal neuron specification (27) . Thus, the signature we uncover identifies striatal identity genes regulated by super-enhancers (20) . Moreover, our results showing that striatal super-enhancer-regulated genes display low RNAPII pausing indicate that super-enhancers drive particular transcription dynamics, implying that enhancer topography influences transcription dynamics. Therefore, we reveal that super-enhancers and low RNAPII pausing define the epigenetic signature of down-regulated genes in HD mouse striatum. Finally, together with previous studies implicating CBP in HD pathogenesis (9, 12) and in regulation of super-enhancers (22) , our data suggest that CBP alteration in HD striatum may contribute to selective decrease in super-enhancer activity. Thus, we provide new insights into the mechanism leading to transcriptional misregulation in HD and raise new therapeutic perspectives, because the identification of a mechanism leading to decreased expression of genes sharing a common epigenetic signature is a prerequisite towards specific targeting of these genes.
In a recent study combining H3K4me3 ChIP-seq and RNA-seq analyses, Vashishtha et al. (8) showed that down-regulated genes in the brain of HD R6/2 mice, including the striatum, predominantly associated with a specific H3K4me3 TSS profile, spreading broadly downstream of the TSS. Genes that displayed this peculiar pattern were enriched in functions and pathways linked to neuronal activity, indicating that broad H3K4me3 profiles also mark genes defining tissue identity and function. Our data revealing that broad patterns of H3K27ac, H3K4me1 and RNAPII mark down-regulated genes in R6/1 striatum are consistent with these results and suggest that extended and high levels of H3K4me3, H3K4me1, H3K27ac and RNAPII along genes likely all define the epigenetic signature of down-regulated genes in HD.
Whether additional histone modifications contribute to the signature will remain to be determined.
CBP-mediated H3K27ac is linked to methyltransferases controlling H3K4 methylation, which allows coordination of H3K4 and H3K27 modifications on transcription activation (41) . The expression of specific down-regulated genes in HD primary neurons was restored upon decrease in Kdm5c (Jarid1c), an enzyme demethylating H3K4me3 and modulating both promoter and enhancer functions (8, 42) . Thus, manipulation of H3K4 methylation in HD neurons may indirectly modulate H3K27ac.
Aberrant methylation of H3K27, which is mediated by polycomb repressive complexes (PRC1 and PCR2), antagonizes acetylation of H3K27 (16) and might contribute to decreased H3K27ac in HD striatum. Despite a role for HTT in facilitating PRC2 and promoting H3K27 trimethylation (H3K27me3) (43), H3K27me3 was not substantially changed in mouse embryonic stem cells (ESCs) and neural progenitor cells (NPCs) expressing mutant HTT, in contrast to ESCs and NPCs deficient for HTT (44) . Moreover, PRC2 protein levels were not modified by the HD mutation (44) . Together, this suggests that alteration of H3K27me3 regulation is unlikely to be a major cause leading to decreased H3K27ac at down-regulated genes in R6/1 striatum.
Combining H3K4me3 ChIP-seq, DNA methylation and gene expression analyses on post-mortem HD human brains, Bai et al. (45) suggested that epigenetic deregulation of HES4, which is closely related to HES1, a critical player during neuronal development, may contribute to HD pathogenesis. The authors hypothesized that HD may comprise a neurodevelopmental component. Thus, preferential down-regulation of super-enhancer-regulated genes in HD could result from altered neuronal differentiation and establishment of tissue-specific enhancers (i.e. super-enhancers). However, our observation that H3K27ac is present at striatal super-enhancers in R6/1 striatum, although in reduced amounts compared with WT, suggests that super-enhancers do establish at proper genomic regions during HD striatum development. Although we do not exclude slight defects during development and differentiation of HD neurons, we favor a scenario where super-enhancer maintenance during adulthood rather than establishment during development is altered in response to the HD mutation.
Our results, together with previous studies (9, 12) showing that the transcriptional coactivator CBP, a component of superenhancers acetylating H3K27 (22) , is progressively altered in HD neurons, support a model where stabilization of superenhancers is impaired in HD-affected neurons. Specific alteration of super-enhancers with respect to typical enhancers may result from a well-documented hallmark of super-enhancers, i.e. their increased vulnerability to perturbation (20, 21, 23, 46) . Thus, down-regulation of neuronal genes in HD striatum might be the consequence of their higher sensitivity to loss of CBP acetyltransferase activity in response to the HD mutation. Additional cofactors or transcription factors, both deregulated in HD neurons and enriched at super-enhancers, might contribute to increased vulnerability of super-enhancers in response to the HD mutation. For instance, striatal super-enhancers are enriched in binding sites for the co-repressor REST/NRSF, which is increased in HD striatum (2) , suggesting that REST/NRSF may also be involved in preferential down-regulation of super-enhancer-regulated genes in HD striatum.
The striatum is preferentially affected in HD. However, additional structures in the brain, including the cortex, also degenerate, whereas other brain regions, such as the cerebellum, are relatively spared. Previous transcriptomic studies performed on HD mice suggest that the degree of transcriptional dysregulation Human Molecular Genetics | 11 by guest on November 7, 2016 http://hmg.oxfordjournals.org/ of a given tissue may correlate with its propensity to degenerate (2) , suggesting that transcriptional dysregulation in HD may contribute to disease tissue selectivity. It will remain to be determined whether down-regulated genes in other HD tissues are under the control of super-enhancers. Whether global features of super-enhancers differ between tissues, for instance, regarding the number of genes they regulate or the level of occupancy by coactivators, may need to be investigated to decipher the mechanism underlying HD tissue selectivity.
The levels of paused RNAPII at promoter regions are dependent on cis-acting elements, including DNA elements such as Inr, DPE, GAGA element and PB (34, 47) . However, RNAPII pausing is a developmentally regulated and tissue-dependent process (48, 49) , suggesting additional mechanisms that modulate RNA-PII pausing. We show that super-enhancer-regulated genes have low RNAPII pausing indices, whereas genes associated with sharp H3K27ac profiles at the TSS region have high RNAPII pausing indices. Thus, our data suggest for the first time that enhancer topography influences RNAPII pausing, which might contribute to tissue-and gene-specific regulation of transcription dynamics.
Enhancers define regions associated with production of noncoding RNAs called enhancer RNAs (eRNAs) (24, 38) . eRNAs produced from RNAPII-paused genes, including immediate early genes, control RNAPII dynamics via an anti-pausing effect, which enables transcription elongation (25, 26) . Super-enhancer activity was associated with production of regulatory eRNAs using macrophages as a model (50) . Whether decreased H3K27ac at super-enhancers leads to alteration of eRNA production in HD-affected neurons and in turn results in reduction of RNAPII along down-regulated genes is an open question.
Using a network-based approach, we showed that downregulated genes that associate with increased RNAPII pausing indices in R6/1 striatum, corresponding to dramatic reduction of RNAPII within gene bodies, had the largest biological impact and a primary effect on neuronal activity. The other epigenetic classes had a narrower biological impact, with primary effects on cell redox, chromatin modification and proteostasis. This analysis further shows that RNAPII signatures in HD mouse striatum are highly informative.
Finally, the integration of our ChIP-seq data on HD R6/1 mice with human transcriptomic data on the striatum of HD patients shows that the epigenetic signature of down-regulated genes is conserved between humans and mice. This conclusion is consistent with results of a previous study, showing that the transcriptomic signature of HD down-regulated genes in the striatum is conserved between HD patients and mice (4) . These results support the view that HD mouse models, including transgenic mice expressing a truncated form of the protein mutated in HD, represent appropriate models to study the HD epigenome and to develop epigenetic strategies aimed at restoring normal gene expression.
Our results revealing that HD epigenetic signature involves super-enhancers suggest that HD is an enhanceropathy (51) and targeting H3K27ac, for instance, using compounds that can specifically activate CBP/p300 histone acetyltransferase function (52) , may be a promising therapeutic option to selectively restore expression of neuronal identity genes. Whether other neurodegenerative diseases also affect enhancer activity and lead to preferential deregulation of super-enhancer-regulated genes is an intriguing hypothesis that may deserve attention, since the identification of such a common mechanism would raise the possibility to develop epigenetic therapies common to several neurodegenerative diseases.
Materials and Methods

Animals
Hemizygous R6/1 (≈150 CAGs) (53) from the Jackson Laboratory were maintained on a mixed CBAxC57BL/6 genetic background. The experimental protocol respects the European directive (Directive 2010/63/UE), have received governmental authorizations and were approved by the local ethical committee of IGBMC. People involved in animal care, killing and tissue preparation have official expertise. Mice were killed at 30 weeks, and their striata were rapidly dissected, snap frozen and stored at −80°C.
Western-blotting experiments
Whole cell extracts from mouse striatum and cerebellum were prepared as previously described (54) . Protein extracts were analyzed on sodium dodecyl sulphate-polyacrylamide gel electrophoresis gels. Rabbit α-Gata2 (Santa Cruz, sc9008), rabbit α-CBP (Santa Cruz, sc369), rabbit α-p300 (Santa Cruz, sc585) and mouse α-β-tubulin (Chemicon) were used at 1:100, 1:500, 1:500 and 1:5000, respectively, and proteins were detected with appropriate peroxidase-conjugated secondary antibodies (Jackson Im-munoResearch Laboratories) and the ECL Chemiluminescence Kit (Pierce or Millipore). Signals were imaged on radiographic films, captured with GeneSnap and quantified with GeneTool software on Syngene Chemigenus XE machine.
RNA extraction, qRT-PCR and RNA-seq analyses
Each sample was prepared from single striatum of R6/1 or WT mouse. Biological triplicates were initially performed for each group. Total RNA was extracted using TRI Reagent (Molecular Research Center) and the Precellys lysing system (Precellys). For qRT-PCR, cDNA were prepared using 1 µg of total RNA, random hexamers and SuperScriptII reverse transcriptase (Invitrogen) according to the manufacturer's instructions. qRT-PCRs were performed on a Light-Cycler Instrument (Roche), using the Light Cycler 480 SYBR Green I Master X 2 Kit (Roche) and specific primers (available upon request). Data were normalized to expression of 18S or Gapdh housekeeping genes. All experiments were performed at least three times in biological triplicates. RNA-seq libraries of template molecules suitable for strand-specific high-throughput DNA sequencing were created using 'TruSeq Stranded Total RNA with Ribo-Zero Gold Prep Kit' (#RS-122-2301, Illumina). Briefly, starting with 1 µg of total RNA, the first step involved the removal of cytoplasmic and mitochondrial ribosomal RNA (rRNA) using biotinylated, target-specific oligos combined with Ribo-Zero rRNA removal beads. Following purification, the RNA was fragmented into small pieces using divalent cations under elevated temperature. The cleaved RNA fragments were copied into single-strand cDNA using reverse transcriptase and random primers, followed by double-strand cDNA synthesis using DNA Polymerase I and RNase H. The double-stranded cDNA fragments were blunted using T4 DNA polymerase, Klenow DNA polymerase and T4 PNK. A single 'A' nucleotide was added to the 3′ ends of the blunt DNA fragments using a Klenow fragment (3′ to 5′ exo minus) enzyme. The cDNA fragments were ligated to double-stranded adapters using T4 DNA Ligase. The ligated products were enriched by PCR amplification [30 s at 98°C; (10 s at 98°C, 30 s at 60°C, 30 s at 72°C) × 12 cycles; 5 min at 72°C]. Then surplus PCR primers were removed by purification using AMPure XP beads (Agencourt Biosciences Corporation). Final cDNA libraries were checked for quality and quantified using 2100 Bioanalyzer (Agilent). The libraries were loaded in the flow cell at 8 p concentration and clusters were generated in the Cbot and sequenced in the Illumina Hiseq 2500 as single-end 50 base reads following Illumina's instructions. Image analysis and base calling were performed using RTA and CASAVA.
mRNA-seq analysis
Reads were mapped onto the mm9 assembly of the mouse genome using Tophat v1.4.1 (55) with Bowtie v0.12.7 aligner (56) . Uniquely aligned reads have been retained for further analyses. Quantification of gene expression was performed using HTSeq v0.5.3p3 (57), using gene annotations from Ensembl release 67. To identify significantly differentially expressed genes between R6/1 and WT, the method proposed by Love et al. (58) and implemented in the DESeq2 Bioconductor package (DESeq2_1.0.19) was used. Resulting P-values were adjusted for multiple testing, using the method described by Benjamini and Hochberg (59) . The analyses were performed on three WT striata (from three different mice) and two R6/1 striata (from two different mice). Animals were sex-matched. Three R6/1 striata were initially used, but one sample was excluded due to aberrant profile using principal component analysis. Although the number of transgenic samples was consequently reduced, limiting statistical power, our results were consistent with previous analyses of differentially expressed genes between HD and control mouse striatum or brain ( Fig. 1 and Supplementary Material, Fig. S3B ). We therefore used our RNA-seq data for subsequent analyses, applying following filters: fold-change >1.5 and adjusted P-value <0.01 were used (Supplementary Material, Table S1 ). Read counts were normalized across libraries with the method proposed by Anders and Huber (60) and divided by gene length (in kb) to obtain normalized RPK values displayed in the figures. Gene expression changes in the brain of R6/1 mice of 22 and 27 weeks were assessed using microarrays from Hodges et al. (6) . Top-ranked genes were used to consider most robust changes (fold-change >1.5 and adjusted P-value <0.01 were used as filters). Gene expression changes in the striatum of R6/2 mice at 12 weeks were assessed using RNA-seq from Vashishtha et al. (8) . Gene expression changes in the striatum of CHL2 mice at 22 weeks were assessed using microarrays from Kuhn et al. (4) . Gene expression changes in caudate nucleus of post-mortem brain from HD patients were generated using microarrays from Hodges et al. (5) . Top-ranked genes were used to consider most robust changes (P-value threshold <10 −10 was used, which resulted in a list of ≈200 genes with corresponding orthologous in the Mouse).
ChIP-seq experiments
ChIP experiments were performed essentially as described (61) . Briefly, for each experiment, striata from four transgenic or control mice were used. Biological replicates were performed using pooled tissues from different mice. Pooled tissues (sex-matched between R6/1 and WT animals) were cut into small fragments, fixed in 1% formaldehyde and incubated for 15 min at room temperature. Cross-linking was stopped by the addition of glycine to a final concentration of 0.125 . Tissue fragments were washed with cold phosphate-buffered saline supplemented with protease inhibitors. The tissues were then homogenized in sonication buffer, and lysates were sonicated to obtain DNA fragments <500 bp and centrifuged. The soluble chromatin fraction was pretreated with protein A Agarose/Salmon Sperm DNA (Millipore) for 1 h at 4°C. Subsequently, samples were incubated overnight at 4°C with antibodies to H3K27ac (Abcam, ab4729), H3K4me1 (Abcam) or 7C2 RNAPII antibody (61) . Protein A Agarose/Salmon Sperm DNA was then added and the mixture was incubated for 3 h at 4°C. Agarose beads were washed, protein-DNA complexes were eluted from the beads and decrosslinked, and DNA recovered by phenol chloroform extraction and ethanol precipitation after treatment with ribonuclease A (Abcam) and proteinase K. Prior to sequencing, ChIP experiments were verified by using q-PCR. ChIP-seq libraries were prepared using NEXTflex ChIP-Seq Kit (#5143-02, Bioo Scientific) following the manufacturer's protocol (V12.10) with some modifications. Briefly, 10 ng of ChIP-enriched DNA or Input DNA were end repaired using T4 DNA polymerase, Klenow DNA polymerase and T4 PNK, then size selected and cleaned-up using Agencourt AMPure XP beads (#A63881, Beckman). A single 'A' nucleotide was added to the 3′ ends of the blunt DNA fragments with a Klenow fragment (3′ to 5′exo minus). The ends of the DNA fragments were ligated to double-stranded barcoded DNA adapters (NEXTflex ChIP-Seq Barcodes-6, #514120, Bioo Scientific) using T4 DNA Ligase. The ligated products were enriched by PCR [2 min at 98°C; (30 s at 98°C, 30 s at 65°C, 60 s at 72°C) × 14 cycles; 4 min at 72°C] and cleanedup using Agencourt AMPure XP beads. Prior to analyses, DNA libraries were checked for quality and quantified using a 2100 Bioanalyzer (Agilent). The libraries were loaded in the flowcell at 8 p concentration and clusters were generated using the Cbot and sequenced on the Illumina Genome Hiseq2500 as single-end 50 base reads following Illumina's instructions. Image analysis and base calling were performed using RTA and CASAVA.
Chip-seq analysis
Reads were mapped onto Mouse reference assembly mm9/ NCBI37 using Bowtie v0.12.7 aligner (56) . Peak detection of RNAPII was performed using MACS v1.4.1 (62) . Peak detection of H3K27ac was performed using SICER v1.1 (63) with the following parameters: window size: 200; gap size: 1000; e-value: 0.003. Peaks were annotated relative to genomic features using Homer Anno-tatePeaks (64) with annotation from Ensembl v67. Global comparison of samples and clustering analysis were performed using seqMINER (65) . As reference coordinates, we used Refseq genes for Mouse mm9 genome. Differential analysis between WT and R6/1 mice was performed using either MACS or SICER for RNAPII and H3K27ac, respectively. Increased and decreased RNAPII regions were selected if their P-values <10 −5 . Increased and decreased H3K27ac regions were selected as significant if their fold change >1.5 and their P-values <10 −5 . All biological replicates were analyzed independently in the same way and compared with custom R scripts and with the Bioconductor package ChIPpeakAnno (66) . Inputs were used as controls. Integrated analysis of RNA-seq and ChIP-seq data was done using the open Galaxy platform GalaxEast (http://www.galaxeast.fr).
Normalization of ChIP-seq data
ChIP-seq data were normalized based on a method that consists of equalizing background regions. Briefly, read counts were computed in 250 000 randomly selected regions of 5000nt in length for each of the samples to normalize. Read counts were then compared across samples and used to estimate a scaling ratio. Finally, the scaling ratio was used to remove randomly chosen reads in the samples to be normalized.
Network-based analysis
RNA-seq and RNAPII ChIP-seq data were analyzed using a previously described network-based approach (67) in which spectral decomposition of the signal-here, the log ratio values for gene expression and the PI ratio values for RNAPII-was performed against MouseNet (68), a probabilistic network providing a reference grid for gene-gene functional interactions in the mouse. We filtered MouseNet to retain only edges with the highest biological significance, namely the edges with a score of 1 after normalization. This custom version of MouseNet has 14 980 genes and 1 640 643 edges, which is less than the original version (15 548 genes and 1 712 906 edges). This resulted into four categories of networks (PI ratio down: 106 modules, PI ratio up: 92 modules, gene up-regulated: 159 modules, gene down-regulated: 127 modules) for a total of 3898 genes. All modules were annotated using KEGG (69) and GO (70) . We then identified 423 gene nodes that were unambiguously associated to each of the four epigenetic classes defined by the RNA-seq and ChIP-seq data and tested for enrichment in KEGG and GO annotations to assess the biological content corresponding to these four gene classes. For a detailed representation of the data, we used heatmaps and Spring layout graphs that were generated using the igraph R package (http://igraph.org).
Motif analysis
Motifs searching of known motifs (Jaspar 2009 motif database) was made using FIMO (71) within regions of interest (core genes of clusters A-F), FIMO results were then processed by a custom Perl script which computed the number of occurrence of each motif. To assess the enrichment of motifs within the regions of interest, the same analysis was done n times (n = 150) on randomly selected regions. Randomly selected regions were used to compute an expected distribution of motif occurrence. Region size distribution of the randomly selected regions was the same as for the regions of interest. The significance of the motif occurrence was estimated through the computation of a Z-score.
The Z-score was computed by
where χ is the observed value (number of motif occurrence), µ is the mean of the number of occurrences (computed on randomly selected data) and σ is the standard deviation of the number of occurrences of motifs (computed on randomly selected data).
From the Z-scores, P-values for each motif were computed. The P-values were corrected for multi-testing with the method proposed by Benjamini and Hochberg (59) . Statistical analysis was done with custom R scripts.
Gene ontology analysis
Functional enrichments in GO terms (CC and MF) and pathways (KEGG, BIOCARTA and MSigDB) were performed using the tools DAVID and/or GREAT (28, 29) . GREAT is more appropriate to ChIP-seq data analysis as it assesses functional enrichments using peak coordinates to assign annotations of nearby genes, whereas DAVID uses genes ID. For analyses with GREAT, defaults setting were used. Whole Mouse genome was used as background. Top-enriched terms are shown (P-values <0.05 were considered).
